From GlobeNewswire: 2025-06-04 09:40:00

The Clinical Trial Management System Market was valued at USD 1.80 billion in 2023 and is projected to reach USD 5.93 billion by 2032, with a CAGR of 14.18%. Factors driving growth include cloud adoption, AI, and real-time data analytics, enhancing operational efficiency. The U.S. market is expected to reach USD 2.55 billion by 2032, with a CAGR of 14.06%, leading in North America.

The enterprise segment dominated the market with a 73% share in 2023, offering strong capabilities for handling complex multi-site clinical trials. Software accounted for 55% of the market share in 2023, meeting the demand for digital tools in trial planning and management. Web & cloud-based solutions led with a 69% market share, providing flexibility and real-time data access.

The CRO segment held a 39% market share in 2023, as pharmaceutical and biotech companies outsource trials to improve efficiency and cut costs. North America led the market with a 51% share in 2023, while Asia-Pacific is set to witness the fastest growth, driven by the rapid increase in clinical trials in countries like China and India.

SNS Insider offers in-depth market research and consulting services to provide clients with essential knowledge to navigate changing market conditions. Through surveys, video talks, and focus groups worldwide, SNS Insider delivers accurate market data, consumer insights, and opinions to empower decision-making with confidence.



Read more at GlobeNewswire: Clinical Trial Management System Market Size to Hit USD